Disseminated histoplasmosis and human immunodeficiency virus type 1 infection: risk factors in Guatemala.
Segura
L
L
Rojas
M
M
Pelaez
N
N
Shor-Posner
G
G
RosaRe
D
D
Moreno
J
J
Klaskala
W
W
Baum
M K
MK
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000453:epidemiology; D000293:Adolescent; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D003695:Delivery of Health Care; D004358:Drug Therapy / Q000191:economics; D006166:Guatemala / Q000453:epidemiology; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1; D006660:Histoplasmosis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D008297:Male; D012189:Retrospective Studies; D012307:Risk Factors
D000935:Antifungal Agents; D017964:Itraconazole; D000666:Amphotericin B